Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9223444rdf:typepubmed:Citationlld:pubmed
pubmed-article:9223444lifeskim:mentionsumls-concept:C0379710lld:lifeskim
pubmed-article:9223444lifeskim:mentionsumls-concept:C0907532lld:lifeskim
pubmed-article:9223444lifeskim:mentionsumls-concept:C0011740lld:lifeskim
pubmed-article:9223444lifeskim:mentionsumls-concept:C1519726lld:lifeskim
pubmed-article:9223444lifeskim:mentionsumls-concept:C0037628lld:lifeskim
pubmed-article:9223444lifeskim:mentionsumls-concept:C0004083lld:lifeskim
pubmed-article:9223444lifeskim:mentionsumls-concept:C0443264lld:lifeskim
pubmed-article:9223444pubmed:issue1lld:pubmed
pubmed-article:9223444pubmed:dateCreated1997-8-7lld:pubmed
pubmed-article:9223444pubmed:abstractTextCaveolin-1 and endothelial nitric oxide synthase (eNOS) are associated within endothelial caveolae. We have shown previously that eNOS is translocated to the detergent-insoluble, cytoskeletal fraction of bovine aortic endothelial cells (BAEC) in response to bradykinin (BK)-stimulation or tyrosine phosphatase inhibition. In the present study, we have examined whether caveolin-1 is similarly translocated in response to these or other stimuli. Exposure of BAEC to the eNOS-activating agonists, BK, histamine, or ATP produces transient increases in the amounts of detergent-insoluble caveolin-1. Increases in insolubility are blocked by tyrosine kinase inhibitors and are potently mimicked by tyrosine phosphatase inhibitors. Increased insolubility is accompanied by an increased association of caveolin-1 with eNOS and inhibition of eNOS catalytic activity. Agonist-activation of eNOS in endothelial cells thus appears to involve tyrosine phosphorylation-dependent changes in the interaction of eNOS with caveolin-1. Increased interaction of eNOS with caveolin-1 may deactivate the enzyme subsequent to its activation by Ca2+/calmodulin.lld:pubmed
pubmed-article:9223444pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9223444pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9223444pubmed:languageenglld:pubmed
pubmed-article:9223444pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9223444pubmed:citationSubsetIMlld:pubmed
pubmed-article:9223444pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9223444pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9223444pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9223444pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9223444pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9223444pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9223444pubmed:statusMEDLINElld:pubmed
pubmed-article:9223444pubmed:monthJullld:pubmed
pubmed-article:9223444pubmed:issn0006-291Xlld:pubmed
pubmed-article:9223444pubmed:authorpubmed-author:VenemaV JVJlld:pubmed
pubmed-article:9223444pubmed:authorpubmed-author:JuHHlld:pubmed
pubmed-article:9223444pubmed:authorpubmed-author:VenemaR CRClld:pubmed
pubmed-article:9223444pubmed:authorpubmed-author:MarreroM BMBlld:pubmed
pubmed-article:9223444pubmed:authorpubmed-author:ZouRRlld:pubmed
pubmed-article:9223444pubmed:issnTypePrintlld:pubmed
pubmed-article:9223444pubmed:day9lld:pubmed
pubmed-article:9223444pubmed:volume236lld:pubmed
pubmed-article:9223444pubmed:ownerNLMlld:pubmed
pubmed-article:9223444pubmed:authorsCompleteYlld:pubmed
pubmed-article:9223444pubmed:pagination155-61lld:pubmed
pubmed-article:9223444pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:9223444pubmed:meshHeadingpubmed-meshheading:9223444-...lld:pubmed
pubmed-article:9223444pubmed:meshHeadingpubmed-meshheading:9223444-...lld:pubmed
pubmed-article:9223444pubmed:meshHeadingpubmed-meshheading:9223444-...lld:pubmed
pubmed-article:9223444pubmed:meshHeadingpubmed-meshheading:9223444-...lld:pubmed
pubmed-article:9223444pubmed:meshHeadingpubmed-meshheading:9223444-...lld:pubmed
pubmed-article:9223444pubmed:meshHeadingpubmed-meshheading:9223444-...lld:pubmed
pubmed-article:9223444pubmed:meshHeadingpubmed-meshheading:9223444-...lld:pubmed
pubmed-article:9223444pubmed:meshHeadingpubmed-meshheading:9223444-...lld:pubmed
pubmed-article:9223444pubmed:meshHeadingpubmed-meshheading:9223444-...lld:pubmed
pubmed-article:9223444pubmed:meshHeadingpubmed-meshheading:9223444-...lld:pubmed
pubmed-article:9223444pubmed:meshHeadingpubmed-meshheading:9223444-...lld:pubmed
pubmed-article:9223444pubmed:year1997lld:pubmed
pubmed-article:9223444pubmed:articleTitleCaveolin-1 detergent solubility and association with endothelial nitric oxide synthase is modulated by tyrosine phosphorylation.lld:pubmed
pubmed-article:9223444pubmed:affiliationVascular Biology Center, Department of Pediatrics, Medical College of Georgia, Augusta 30912, USA.lld:pubmed
pubmed-article:9223444pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9223444pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:9223444pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9223444lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9223444lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9223444lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9223444lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9223444lld:pubmed